These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 12630043

  • 1. Prognostic value of preoperative immunosuppressive acidic protein levels in patients with gastric carcinoma.
    Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K.
    Hepatogastroenterology; 2003; 50(49):289-92. PubMed ID: 12630043
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: a multivariate analysis.
    Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K.
    Am J Gastroenterol; 2001 Feb; 96(2):574-8. PubMed ID: 11232710
    [Abstract] [Full Text] [Related]

  • 3. Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
    Sakamoto J, Teramukai S, Koike A, Saji S, Ohashi Y, Nakazato H.
    Cancer; 1996 Jun 01; 77(11):2206-12. PubMed ID: 8635085
    [Abstract] [Full Text] [Related]

  • 4. Preoperative plasma fibrinogen levels in gastric cancer patients correlate with extent of tumor.
    Lee JH, Ryu KW, Kim S, Bae JM.
    Hepatogastroenterology; 2004 Jun 01; 51(60):1860-3. PubMed ID: 15532844
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of level and number of lymph node metastases in patients with gastric cancer.
    Saito H, Fukumoto Y, Osaki T, Fukuda K, Tatebe S, Tsujitani S, Ikeguchi M.
    Ann Surg Oncol; 2007 May 01; 14(5):1688-93. PubMed ID: 17245613
    [Abstract] [Full Text] [Related]

  • 6. Disseminated tumor cells in the blood of patients with gastric cancer are an independent predictive marker of poor prognosis.
    Illert B, Fein M, Otto C, Cording F, Stehle D, Thiede A, Timmermann W.
    Scand J Gastroenterol; 2005 Jul 01; 40(7):843-9. PubMed ID: 16109661
    [Abstract] [Full Text] [Related]

  • 7. [Clinical investigation of serum immunosuppressive acidic protein (IAP) in patients with gastric cancer].
    Kageyama T, Oyabu H, Ohshiba S.
    Gan No Rinsho; 1986 Sep 01; 32(11):1416-20. PubMed ID: 3773269
    [Abstract] [Full Text] [Related]

  • 8. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M, Dilege E, Demir U, Coskun H, Eroglu T, Uysalol MD.
    Hepatogastroenterology; 2004 Sep 01; 51(59):1544-7. PubMed ID: 15362797
    [Abstract] [Full Text] [Related]

  • 9. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
    Toiyama Y, Miki C, Inoue Y, Okugawa Y, Koike Y, Watanabe H, Yokoe T, Hiro J, Ojima E, Tanaka K, Kusunoki M.
    J Surg Oncol; 2008 Apr 01; 97(5):404-8. PubMed ID: 18181167
    [Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of the serum level of immunosuppressive acidic protein (IAP) and immunosuppressive substance (IS) in gastric cancer patients].
    Sakita M, Yamane T, Kasuga M, Torii T, Imai H, Kageyama N, Fujita Y, Majima S.
    Gan To Kagaku Ryoho; 1982 Oct 01; 9(10):1755-64. PubMed ID: 7184372
    [Abstract] [Full Text] [Related]

  • 11. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
    Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, Ozmen V, Gulluoglu M, Kapran Y.
    Hepatogastroenterology; 2009 Oct 01; 56(91-92):908-13. PubMed ID: 19621727
    [Abstract] [Full Text] [Related]

  • 12. Detection of circulating gastric cancer cells in peripheral blood using real time quantitative RT-PCR.
    Koga T, Tokunaga E, Sumiyoshi Y, Oki E, Oda S, Takahashi I, Kakeji Y, Baba H, Maehara Y.
    Hepatogastroenterology; 2008 Oct 01; 55(84):1131-5. PubMed ID: 18705345
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
    Marchet A, Mocellin S, Ambrosi A, de Manzoni G, Di Leo A, Marrelli D, Roviello F, Morgagni P, Saragoni L, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D, Italian Research Group for Gastric Cancer Study (GIRCG).
    Eur J Surg Oncol; 2008 Feb 01; 34(2):159-65. PubMed ID: 17566691
    [Abstract] [Full Text] [Related]

  • 14. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
    Wang CS, Wu TL, Tsao KC, Sun CF.
    Ann Clin Lab Sci; 2006 Feb 01; 36(1):23-30. PubMed ID: 16501233
    [Abstract] [Full Text] [Related]

  • 15. Choice of the surgical treatment in early gastric cancer.
    Custureri F, D'Orazi V, Peparini N, Gabatel R, Urciuoli P, Patrizi G, Redler A, Di Matteo G.
    Hepatogastroenterology; 2004 Feb 01; 51(58):1210-4. PubMed ID: 15239281
    [Abstract] [Full Text] [Related]

  • 16. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
    Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.
    Br J Dermatol; 2008 Sep 01; 159(3):597-605. PubMed ID: 18616789
    [Abstract] [Full Text] [Related]

  • 17. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
    Lindebjerg J, Spindler KL, Ploen J, Jakobsen A.
    Colorectal Dis; 2009 Mar 01; 11(3):264-9. PubMed ID: 18573119
    [Abstract] [Full Text] [Related]

  • 18. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I, Maehara Y, Koga T, Sumiyoshi Y, Oshiro T, Baba H, Kohnoe S, Okamura T, Uike N, Matsusaka T, Kume K, Sugimachi K.
    Hepatogastroenterology; 2003 Mar 01; 50(51):877-82. PubMed ID: 12828109
    [Abstract] [Full Text] [Related]

  • 19. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
    Romano F, Cesana G, Berselli M, Gaia Piacentini M, Caprotti R, Bovo G, Uggeri F.
    J Surg Oncol; 2004 Dec 15; 88(4):240-7. PubMed ID: 15565596
    [Abstract] [Full Text] [Related]

  • 20. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.
    Acta Obstet Gynecol Scand; 2008 Dec 15; 87(11):1136-42. PubMed ID: 18951217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.